High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.8M
$10,756,932
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CRSP |
CRISPR Therapeutics AG
|
CEO
Sell to Cover
|
2026-03-23 | $468,736 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CEO
Sell to Cover
|
2026-03-16 | $499,443 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CEO
Sell to Cover
|
2026-03-11 | $517,334 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CEO
Sell to Cover
|
2026-02-19 | $366,325 | S | Form 4 |
|
CRSP
S
CRISPR Therapeutics AG
Kulkarni Samarth
• CEO
10b5-1 SellΔOwn -30.9%
2026-01-22
$3,613,800Large
|
||||||
| CRSP |
CRISPR Therapeutics AG
|
CEO
10b5-1 SellΔOwn -30.9%
|
2026-01-22 | $3,613,800Large | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CEO
10b5-1 Sell
|
2026-01-20 | $446,341 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CEO
10b5-1 Sell
|
2026-01-20 | $1,106,157Large | S | Form 4 |
|
CRSP
S
CRISPR Therapeutics AG
Kulkarni Samarth
• CEO
Sell to CoverΔOwn -16.7%
2025-10-17
$3,456,279Large
|
||||||
| CRSP |
CRISPR Therapeutics AG
|
CEO
Sell to CoverΔOwn -16.7%
|
2025-10-17 | $3,456,279Large | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CEO
Sell to Cover
|
2025-10-14 | $282,517 | S | Form 4 |